Testing effectiveness (Phase 2)Ended earlyNCT03354754
What this trial is testing
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
Who this might be right for
Intra-abdominal Infections
Novartis Pharmaceuticals 3